The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

• Status: Recruiting
• Trial end date: 2022-10-01

Summary

The purpose of this study is to observe and evaluate the efficacy and safety of SHR-1210 combined with preoperative chemotherapy for locally advanced esophageal squamous cell carcinoma

• Phase: Phase 2

Details

• Lead Sponsor: The First Affiliated Hospital of Zhengzhou University
• Collaborator: Jiangsu HengRui Medicine Co., Ltd.
• Treatments: Albumin-Bound Paclitaxel; Docetaxel; Nedaplatin; Paclitaxel